Reported Monday, Valneva Withdraws IXCHIQ Chikungunya Vaccine BLA And IND In The US Following FDA Suspension And New Serious Adverse Event Review
Benzinga Newsdesk 9 months ago
News
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and commercial attractiveness
- Company voluntarily withdraws IXCHIQ BLA and IND in the U.S.
- Continuing review of global product opportunity according to medical need and commercial attractiveness